RE:RE:RE:RE:Example of a jv deal Well, since no one really answered the question. I asked ChatGPT the general question:
What percentage of promising cancer treatments actually get commercialized?
>
The percentage of promising cancer treatments that actually get commercialized can vary widely depending on various factors such as the type of cancer, the stage of development of the treatment, the success rate in clinical trials, and the regulatory and financial hurdles to getting a treatment approved and to market.
It is difficult to give a precise figure, but according to a report by the Pharmaceutical Research and Manufacturers of America (PhRMA), only about 12% of cancer drugs that enter clinical trials are ultimately approved by the US Food and Drug Administration (FDA) for commercialization. However, this figure only represents drugs that make it to clinical trials, and many more treatments never make it that far due to lack of funding, poor results in preclinical studies, or other reasons.
It's worth noting that even after a treatment is approved by the FDA, it can take several more years and significant investment to bring it to market and make it widely available to patients. Additionally, not all promising cancer treatments are developed by pharmaceutical companies; some may be developed by academic researchers or small biotech firms that may face additional challenges in commercializing their products.